Pharmaceutical intermediates

Isavuconazonium sulfate Intermediates

4 pharmaceutical intermediates for Isavuconazonium sulfate. Indication: Aspergillus Infection; Cryptosporidium Infection; Fungal Infection; Mucorales Infection.

提交项目 All intermediates

About Isavuconazonium sulfate

Originator: Basilea Pharmaceutica Ltd..
Indication: Aspergillus Infection; Cryptosporidium Infection; Fungal Infection; Mucorales Infection
Approved Date: 03/06/2015
NCE Patent: 09/06/2026
DS/DP: 10/31/2025

Available intermediates

4 intermediates currently listed for Isavuconazonium sulfate. Request specifications, documentation or a quotation for any item below.

Isavuconazonium sulfate intermediates
Product Name	CAS No.	Molecular Formula	Physical Properties
(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyraMide	368421-58-3	/	/
1-(((2R,3S)-2-(2,5-difluorophenyl)-3-Methyloxiran-2-yl)Methyl)-1H-1,2,4-triazole	241479-73-2	/	/
4-(2-Bromoacetyl)benzonitrile	20099-89-2	/	/
(2-(((1-Chloroethoxy)carbonyl)(methyl)amino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate	338990-31-1	/	/

Other programs under I

Ibrutinib/ Zanubrutinib Iguratimod Imatinib Imeglimin hydrochloride Indacaterol Maleate Infigratinib Ipatacopan Hydrochloride Ipragliflozin

Building toward Isavuconazonium sulfate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →